{
  "schemaVersion" : 2,
  "registerId" : "F2017L00006",
  "instrumentNumber" : "5/2017",
  "citation" : "Statement of Principles concerning relapsing polychondritis (Reasonable Hypothesis) (No. 5 of 2017)",
  "conditionName" : "relapsing polychondritis",
  "effectiveFrom" : "2017-01-23",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "M94.1"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "receiving treatment with a tumour necrosis factor alpha inhibitor\r\nwithin the three months before the clinical onset of relapsing\r\npolychondritis",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(2)",
    "text" : "inability to obtain appropriate clinical management for relapsing\r\npolychondritis",
    "definedTerms" : [ ]
  } ]
}